The protective effect of dexmedetomidine against acute kidney injury in sepsis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230925003

Enrollment

331

Registered

2023-09-25

Start date

2021-12-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury in sepsis. acute kidney injury, sepsis, dexmedetomidine

Interventions

Patients who received dexmedetomidine.,Patients who did not receive dexmedetomidine

Prevention,Prevention

Dexmedetomidine group,Non dexmedetomidine group

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients who were admitted to the ICU with the diagnosis of sepsis.

Exclusion criteria

Exclusion criteria: ESRD, pregnancy

Design outcomes

Primary

Measure	Time frame
Acute kidney injury 7 days Percents	—

Secondary

Measure	Time frame
Mortality 30 days Percents	—

Countries

Thailand

Contacts

Public ContactChawika Pisitsak

Faculty of Medicine Ramathibodi Hospital

chawika_p@hotmail.com0982541952

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026